Results 121 to 130 of about 337 (145)

Paclitaxel/pexidartinib

Reactions Weekly, 2020
openaire   +1 more source

Pexidartinib hydrochloride exposure induces developmental toxicity and immunotoxicity in zebrafish embryos via activation of Wnt signaling

Fish and Shellfish Immunology, 2023
Jianjun Chen, Dou Yang, Guilan Chen
exaly  

Long-term outcomes of pexidartinib in tenosynovial giant cell tumors

Cancer, 2021
William D Tap, Hans J. Gelderblom, John H. Healey   +2 more
exaly  

Pexidartinib

Reactions Weekly, 2018
openaire   +1 more source

Pexidartinib

Reactions Weekly
openaire   +2 more sources

Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors

Journal of Clinical Pharmacology, 2021
William D Tap, Hans J. Gelderblom, John H. Healey   +2 more
exaly  

Synthesis of Pexidartinib

Synfacts, 2019
openaire   +1 more source

Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics

Journal of Clinical Pharmacology, 2022
William D Tap, John H. Healey, Silvia Stacchiotti   +2 more
exaly  

Development of UPLC–MS/MS method for studying the pharmacokinetic interactions of pexidartinib with antifungal drugs in rats

Journal of Pharmaceutical and Biomedical Analysis, 2020
Ren-ai Xu, Bowen Zhang, Congrong Tang
exaly  

Pharmacokinetics of the Multi-kinase Inhibitor Pexidartinib: Mass Balance and Dose Proportionality

Clinical Pharmacology in Drug Development, 2023
Hamim Zahir
exaly